SGLT2 Inhibitors After Acute Kidney Injury With Indications Pilot
Sponsor: University of Minnesota
Terminated
Poor recruitment
Other terminated trials from University of Minnesota
Other Acute Kidney Injury trials with similar outcome
A EARLY_PHASE1 clinical study on Acute Kidney Injury, this trial is terminated or withdrawn. The trial is conducted by University of Minnesota and has accumulated 6 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated EARLY_PHASE1
Status: Recruiting → Terminated
-
Jul 2024 — Sep 2024 [monthly]
Recruiting EARLY_PHASE1
-
Jun 2024 — Jul 2024 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Apr 2024 — Jun 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Mar 2024 — Apr 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
▶ Show 1 earlier version
-
Dec 2023 — Mar 2024 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Minnesota
For direct contact, visit the study record on ClinicalTrials.gov .